{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Therapeutic_Angiotensin-1-7",
  "nciThesaurus": {
    "casRegistry": "51833-78-4",
    "chebiId": "CHEBI:55438",
    "chemicalFormula": "",
    "definition": "A synthetic heptapeptide identical to endogenous angiotensin-(1-7) with vasodilator and antiproliferative activities. Therapeutic angiotensin 1-7 may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) receptor Mas, resulting in diminished tumor cell proliferation. Activation of the angiotensin-(1-7) receptor Mas, a G-protein coupled, seven transmembrane protein, may down-regulate the phosphorylation and activation of Erk1 and Erk2 in the Erk1/Erk2 MAPK signaling pathway. In the renin-angiotensin system, the vasodilating activity of angiotensin- (1-7), hydrolysed from angiotensin II by the type I transmembrane metallopeptidase and carboxypeptidase angiotensin converting enzyme 2 (ACE2) in vivo, counteracts the vasoconstricting activity of angiotensin II.",
    "fdaUniiCode": "IJ3FUK8MOF",
    "identifier": "C68962",
    "preferredName": "Therapeutic Angiotensin-(1-7)",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C307"
    ],
    "synonyms": [
      "ANGIOTENSIN 1-7",
      "Ang 1-7",
      "Angiotensin 1-7",
      "TXA 127",
      "TXA-127",
      "TXA127",
      "Therapeutic Angiotensin-(1-7)",
      "therapeutic angiotensin-(1-7)"
    ]
  }
}